Contact information
Type
Scientific
Primary contact
Prof Hans Wilhelm Hoepp
ORCID ID
Contact details
Kerpener Str. 62
Cologne
50937
Germany
hw.hoepp@uni-koeln.de
Additional identifiers
EudraCT number
ClinicalTrials.gov number
Protocol/serial number
3
Study information
Scientific title
Acronym
HEP III
Study hypothesis
Innovative ways for dissemination of guidelines are superior to traditional ways.
Ethics approval
All participants took part voluntarily and the interventions were optional therefore ethics approval was not necessary.
Study design
Randomised controlled trial
Primary study design
Interventional
Secondary study design
Randomised controlled trial
Trial setting
Not specified
Trial type
Quality of life
Patient information sheet
Condition
Hypertension
Intervention
1. Guideline in print
2. Interactive guideline
3. Expert seminars
4. Control group
The intervention groups were 3825 physicians for the expert seminars and always 1500 for the guideline in print, the interactive guideline and the control group. The medium follow-up time after intervention was approximately six months.
Intervention type
Other
Phase
Not Specified
Drug names
Primary outcome measure
Difference in guideline awareness between trained physicians and the control group.
Secondary outcome measures
Overall guideline awareness.
Overall trial start date
01/01/2004
Overall trial end date
31/03/2005
Reason abandoned (if study stopped)
Eligibility
Participant inclusion criteria
Participants of HEP I-trial: In the HEP-I trial we explored the guideline awareness of 24899 German physicians, including all internists, cardiologists and 22% of general practitioners in a nationwide survey. The data is already published (see http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=11677375)
Participant type
Patient
Age group
Adult
Gender
Both
Target number of participants
8325
Participant exclusion criteria
See inclusion criteria.
Recruitment start date
01/01/2004
Recruitment end date
31/03/2005
Locations
Countries of recruitment
Germany
Trial participating centre
Kerpener Str. 62
Cologne
50937
Germany
Sponsor information
Organisation
University of Cologne (Germany)
Sponsor details
Koeln Fortune Program
Faculty of Medicine
Kerpener Str. 62
Cologne
50937
Germany
t.hensler@uni-koeln.de
Sponsor type
University/education
Website
Funders
Funder type
University/education
Funder name
University of Cologne (Germany) - Koeln Fortune Program, Faculty of Medicine
Alternative name(s)
Funding Body Type
Funding Body Subtype
Location
Results and Publications
Publication and dissemination plan
Not provided at time of registration
Intention to publish date
Participant level data
Not provided at time of registration
Basic results (scientific)
Publication list